首页> The Journal of dermatology> Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice.

Topical administration of nanocarrier miRNA-210 antisense ameliorates imiquimod-induced psoriasis-like dermatitis in mice.

导出原文传递

翻译打印收藏纠错

第一作者： Huan,Feng

第一单位： Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.;Research Unit of Key Technologies of Immune-related Skin Diseases Diagnosis and Treatment, Chinese Academy of Medical Sciences, Changsha, China.

作者： Huan,Feng ^[1] ; Ruifang,Wu ^[1] ; Suhan,Zhang ^[1] ; Yi,Kong ^[1] ; Zixin,Liu ^[1] ; Haijing,Wu ^[1] ; Honglin,Wang ^[2] ; Yuwen,Su ^[1] ; Ming,Zhao ^[1] ; Qianjin,Lu ^[1]

作者单位： Department of Dermatology, Hunan Key Laboratory of Medical Epigenomics, The Second Xiangya Hospital of Central South University, Changsha, China.;Research Unit of Key Technologies of Immune-related Skin Diseases Diagnosis and Treatment, Chinese Academy of Medical Sciences, Changsha, China. ^[1] Key Laboratory of Cell Differentiation Apoptosis of Chinese Ministry of Education, Shanghai Institute of Immunology, Shanghai Jiao Tong University School of Medicine (SJTU-SM), Shanghai, China. ^[2]

关键词 T cell miRNA-210 antisense psoriasis reconstituted high-density lipoprotein nanocarrier treatment